Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PHF3 | Human | (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of PHF3 mRNA | CTD | PMID:16949557 | PHF3 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Phf3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of PHF3 mRNA | CTD | PMID:22206623 | PHF3 | Human | 1,2-dimethylhydrazine | affects expression | ISO | Phf3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of PHF3 mRNA | CTD | PMID:22206623 | PHF3 | Human | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | ISO | Phf3 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:23829299 | PHF3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Phf3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PHF3 mRNA | CTD | PMID:19465110 | PHF3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Phf3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PHF3 mRNA | CTD | PMID:32109520 | PHF3 | Human | 2,4-dinitrotoluene | affects expression | ISO | Phf3 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of PHF3 mRNA | CTD | PMID:21346803 | PHF3 | Human | aflatoxin B1 | increases expression | ISO | Phf3 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of PHF3 mRNA | CTD | PMID:19770486 | PHF3 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of PHF3 mRNA and aristolochic acid I results in decreased expression of PHF3 protein | CTD | PMID:33212167 | PHF3 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to PHF3 mRNA] | CTD | PMID:32406909 | PHF3 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of PHF3 promoter | CTD | PMID:27901495 | PHF3 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:26238291 | PHF3 | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of PHF3 mRNA | CTD | PMID:38218311 | PHF3 | Human | bisphenol A | increases expression | ISO | Phf3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of PHF3 mRNA | CTD | PMID:26063408 | PHF3 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of PHF3 gene | CTD | PMID:31601247 | PHF3 | Human | bisphenol A | decreases expression | ISO | Phf3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of PHF3 mRNA | CTD | PMID:33221593 | PHF3 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PHF3 mRNA | CTD | PMID:29275510 | PHF3 | Human | bisphenol A | increases expression | ISO | Phf3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PHF3 mRNA | CTD | PMID:25181051 more ... | PHF3 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of PHF3 mRNA | CTD | PMID:38568856 | PHF3 | Human | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of PHF3 protein | CTD | PMID:35688186 | PHF3 | Human | carbon nanotube | decreases expression | ISO | Phf3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | PHF3 | Human | chromium(6+) | multiple interactions | EXP | | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PHF3 mRNA | CTD | PMID:38479592 | PHF3 | Human | clobetasol | decreases expression | ISO | Phf3 (Mus musculus) | 6480464 | Clobetasol results in decreased expression of PHF3 mRNA | CTD | PMID:27462272 | PHF3 | Human | clorgyline | increases expression | EXP | | 6480464 | Clorgyline results in increased expression of PHF3 mRNA | CTD | PMID:19691856 | PHF3 | Human | cobalt dichloride | increases expression | ISO | Phf3 (Rattus norvegicus) | 6480464 | cobaltous chloride results in increased expression of PHF3 mRNA | CTD | PMID:24386269 | PHF3 | Human | cyclosporin A | affects expression | ISO | Phf3 (Mus musculus) | 6480464 | Cyclosporine affects the expression of PHF3 mRNA | CTD | PMID:19770486 | PHF3 | Human | DDT | decreases methylation | ISO | Phf3 (Rattus norvegicus) | 6480464 | DDT results in decreased methylation of PHF3 gene | CTD | PMID:30207508 | PHF3 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of PHF3 mRNA | CTD | PMID:37042841 | PHF3 | Human | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of PHF3 mRNA | CTD | PMID:35967413 | PHF3 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF3 mRNA | CTD | PMID:27188386 | PHF3 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of PHF3 mRNA | CTD | PMID:29803840 | PHF3 | Human | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of PHF3 mRNA | CTD | PMID:19244175 | PHF3 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PHF3 protein | CTD | PMID:23301498 | PHF3 | Human | finasteride | increases expression | ISO | Phf3 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of PHF3 mRNA | CTD | PMID:24136188 | PHF3 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of PHF3 protein | CTD | PMID:37730182 | PHF3 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of PHF3 gene | CTD | PMID:31601247 | PHF3 | Human | gentamycin | increases expression | ISO | Phf3 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of PHF3 mRNA | CTD | PMID:33387578 | PHF3 | Human | isoprenaline | increases expression | ISO | Phf3 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of PHF3 mRNA | CTD | PMID:20003209 | PHF3 | Human | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of PHF3 mRNA | CTD | PMID:28988120 | PHF3 | Human | melphalan | decreases expression | EXP | | 6480464 | Melphalan results in decreased expression of PHF3 mRNA | CTD | PMID:22363485 | PHF3 | Human | N,N-diethyl-m-toluamide | multiple interactions | ISO | Phf3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of PHF3 gene | CTD | PMID:33148267 | PHF3 | Human | nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of PHF3 mRNA | CTD | PMID:16949557 | PHF3 | Human | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of PHF3 mRNA | CTD | PMID:27153767 | PHF3 | Human | permethrin | multiple interactions | ISO | Phf3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of PHF3 gene | CTD | PMID:33148267 | PHF3 | Human | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of PHF3 mRNA | CTD | PMID:19159669 | PHF3 | Human | quercetin | increases phosphorylation | EXP | | 6480464 | Quercetin results in increased phosphorylation of PHF3 protein | CTD | PMID:35688186 | PHF3 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of PHF3 mRNA | CTD | PMID:23557933 | PHF3 | Human | rotenone | increases expression | ISO | Phf3 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of PHF3 mRNA | CTD | PMID:19013527 | PHF3 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF3 mRNA | CTD | PMID:27188386 | PHF3 | Human | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of PHF3 mRNA | CTD | PMID:19244175 | PHF3 | Human | sodium fluoride | decreases expression | ISO | Phf3 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of PHF3 mRNA | CTD | PMID:27862939 | PHF3 | Human | succimer | multiple interactions | ISO | Phf3 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHF3 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PHF3 mRNA | CTD | PMID:21641980 and PMID:26378955 | PHF3 | Human | testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of PHF3 mRNA | CTD | PMID:17440010 | PHF3 | Human | titanium dioxide | increases expression | ISO | Phf3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of PHF3 mRNA | CTD | PMID:23557971 | PHF3 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of PHF3 mRNA | CTD | PMID:26272509 | PHF3 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of PHF3 mRNA | CTD | PMID:28542535 | PHF3 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF3 mRNA | CTD | PMID:27188386 | PHF3 | Human | troglitazone | decreases expression | ISO | Phf3 (Mus musculus) | 6480464 | troglitazone results in decreased expression of PHF3 mRNA | CTD | PMID:28973697 | PHF3 | Human | tungsten | decreases expression | ISO | Phf3 (Mus musculus) | 6480464 | Tungsten results in decreased expression of PHF3 mRNA | CTD | PMID:30912803 | PHF3 | Human | valproic acid | affects expression | ISO | Phf3 (Mus musculus) | 6480464 | Valproic Acid affects the expression of PHF3 mRNA | CTD | PMID:17963808 | PHF3 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of PHF3 mRNA | CTD | PMID:23179753 more ... | PHF3 | Human | vitamin E | decreases expression | EXP | | 6480464 | Vitamin E results in decreased expression of PHF3 mRNA | CTD | PMID:19244175 | |